Journal of Music Therapy2001 Win; 38(4): 273-90
ABSTRACT: This study examined the effects of a Music Therapy Voice Protocol (MTVP) on speech intelligibility, vocal intensity, maximum vocal range, maximum duration of sustained vowel phonation, vocal fundamental frequency, vocal fundamental frequency variability, and mood of individuals with Parkinson’s disease. Four female patients, who demonstrated voice and speech problems,served as their own controls and participated in baseline assessment (study pretest), a series of MTVP sessions involving vocal and singing exercises,and final evaluation (study posttest). In study pre and posttests, data for speech intelligibility and all acoustic variables were collected.Statistically significant increases were found in speech intelligibility,as rated by caregivers, and in vocal intensity from study pretest to post test as the results of paired samples t-tests. In addition, before and after each MTVP session (session pre and posttests), self-rated mood scores and selected acoustic variables were collected. No significant differences were found in any of the variables from the session pretests to posttests,across the entire treatment period, or their interactions as the results of two-way ANOVAs with repeated measures. Although not significant, the mean of mood scores in session posttests (M = 8.69) was higher than that in session pretests (M = 7.93).
© SOTO-USA 2025 - All rights are reserved by SOTO-USA to the electronically printed material herein.
This SOT Literature Page and all its contents herein are published by SOTO-USA solely for the purpose of education. All rights reserved by SOTO-USA to accept, reject or modify any submission for publication. The opinions stated in the electronically printed material herein are those of the authors and do not necessarily represent the opinions of SOTO-USA or other individuals associated with SOTO-USA. SOTO-USA does not guarantee or make any representation that the printed material contained herein is valid, reliable or accurate. SOTO-USA does not assume any responsibility for injury arising from any use or misuse of the printed material herein. The printed material contained herein is assumed to be from reliable sources and there is no implication that the printed material herein present the only, or the best methodologies or procedures for the care or treatment of conditions discussed. It is incumbent upon the reader to verify the accuracy of any diagnosis and treatment information contained herein, and to make modifications as new information and/or research arises.
Vist the wisdom, skill, and humor of Dr. DeJarnette the developer of Sacro Occipital Technique.
Major Bertrand DeJarnette, DC, was a renowned inventor, engineer, osteopath, and chiropractor throughout his long and productive career.